Sana Biotechnology
About:
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Website: http://sana.com/
Top Investors: F-Prime Capital, ARCH Venture Partners, Google Ventures, CPP Investments, Alaska Permanent Fund
Description:
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
$865M
Seattle, Washington, United States
2018-01-01
contact(AT)sana.com
Exited Unicorn
Geoffrey von Maltzahn, Jack Milwid, Jacob Rubens, Michael Mee, Sonja Schrepfer, Steve Harr
251-500
2024-02-08
Public
© 2025 bioDAO.ai